PTK2 and cancer: We next evaluated by immunohistochemistry the expression of various SRC effectors, such as CTTN, FAK, and ASAP1, known to regulate tumor invasion, metastasis, and aggressive phenotypes in HNSCC and other cancers [11,12,13,14,15,16,17,37,38,39].